Table 4. Comparison of co-infection and triple infection between the Chinese IDUs and the Burmese male IDUs.
| Parameter | HIV-HBV | HIV-HCV | HBV-HCV | HIV-HBV-HCV | ||||||||
| ChineseIDUs | BurmeseIDUs | P | ChineseIDUs | Burmese IDUs | P | ChineseIDUs | Burmese IDUs | P | ChineseIDUs | Burmese IDUs | P | |
| Age (Mean±SD) | 34.6±7.5 | 30.6±7.0 | <0.01 | 33.7±7.9 | 30.6±6.7 | <0.01 | 34.9±9.0 | 31.6±7.2 | <0.01 | 34.7±7.5 | 30.8±6.1 | <0.05 |
| MaleGendera | 78/399(19.5%) | 36/279(12.9%) | <0.05 | 127/399(31.8%) | 74/279(26.5%) | NS | 147/399(36.8%) | 72/279(25.8%) | <0.005 | 74/399(18.5%) | 33/279(11.8%) | <0.05 |
| Ethnicity | ||||||||||||
| Hanb | 26/166(15.7%) | 7/82(8.5%) | NS | 46/166(27.7%) | 15/82(18.3%) | NS | 51/166(30.7%) | 16/82(19.5%) | NS | 25/166(15.1%) | 6/82(7.3%) | NS |
| Daic | 42/168(25%) | 4/44(9.1%) | <0.05 | 54/168(32.1%) | 7/44(15.9%) | <0.05 | 74/168(44.0%) | 9/44(20.5%) | <0.005 | 39/168(23.2%) | 3/44(6.8%) | <0.001 |
| Jingpod | 12/53(22.6%) | 15/138(10.9%) | <0.05 | 24/53(45.3%) | 39/138(28.3%) | <0.05 | 19/53(35.8%) | 34/138(24.6%) | NS | 12/53(22.6%) | 14/138(10.1%) | NS |
IDUs, intravenous drug users; NS, not significant.
a
Infected male gender versus total male gender.
b
Infected Han group versus total Han group.
c
Infected Dai group versus total Dai group.
d
Infected Jingpo group versus total Jingpo group.